Engaged Capital 13F, Q2 2026

Glenn Welling · quarter ending 30 June 2026 · filed 14 August 2026 · SEC CIK 1559771

$327.08M
Filed US book
10
Positions
23.1%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q2 2026

Weights are against the whole filed book. Changes are in shares held, against the Q1 2026 filing.

CompanyTickerValue% of bookvs Q1 2026
V F CORPVFC$75.43M23.1%-3% shares
YETI HLDGS INCYETI$59.18M18.1%-33% shares
GXO LOGISTICS INCORPORATEDGXO$49.93M15.3%+20% shares
EVOLENT HEALTH INCEVH$30.16M9.2%unchanged
FRESHPET INCFRPT$28.66M8.8%new
COGNEX CORPCGNX$24.55M7.5%-30% shares
BLACKLINE INCBL$23.23M7.1%-40% shares
PORTILLOS INCPTLO$16.32M5.0%unchanged
BRC INCBRCC$15.47M4.7%unchanged
EVOLENT HEALTH INCEVH 3.5 12/01/29$4.16M1.3%new

What changed since Q1 2026

Against the Q1 2026 filing, Engaged Capital opened 2 new positions, added to 1, trimmed 4, left 3 unchanged and exited 0. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

  • FRPT$28.66M
  • EVH 3.5 12/01/29$4.16M

Exited

Nothing from the previous filing was sold outright.

Added to

Trimmed

Other quarters

Source: SEC Form 13F-HR, accession 0000921895-26-002154, filed by Engaged Capital LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.